Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 24, 2023 16:30 ET | Source: Neuronetics

Neuronetics to Present at the William Blair 43rd Annual Growth Stock Conference

MALVERN, Pa., May 24, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “company” or “Neuronetics”), a commercial stage medical technology company with a strategic vision of...
May 23, 2023 08:46 ET | Source: Neuronetics

New Depression Barometer Survey Shows Patients Are Stopping Treatment Due to Dissatisfaction

MALVERN, Pa., May 23, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
May 15, 2023 08:56 ET | Source: Neuronetics

Neuronetics Wins 2023 Bell Seal for Workplace Mental Health

MALVERN, Pa., May 15, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
May 09, 2023 17:00 ET | Source: Neuronetics

Neuronetics to Present at the JMP Securities Life Sciences Conference

MALVERN, Pa., May 09, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “company” or Neuronetics”) a commercial stage medical technology company with a strategic vision of transforming...
May 09, 2023 07:30 ET | Source: Neuronetics

Neuronetics Reports Record First Quarter 2023 Financial and Operating Results

MALVERN, Pa., May 09, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “company” or Neuronetics”) a commercial stage medical technology company with a strategic vision of transforming...
May 08, 2023 08:47 ET | Source: Neuronetics

Neuronetics Receives MDSAP Certification and CE Mark Certification under New MDR

MALVERN, Pa., May 08, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
May 05, 2023 08:30 ET | Source: Neuronetics

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

MALVERN, Pa., May 05, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
May 03, 2023 08:58 ET | Source: Neuronetics

Neuronetics Showcases New NeuroStar® TMS Findings at Clinical TMS Society Annual Meeting

MALVERN, Pa., May 03, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
May 02, 2023 09:01 ET | Source: Neuronetics

NeuroStar® Expands “Tap Into Possibility” Campaign in Honor of Mental Health Awareness Month

A Media Snippet accompanying this announcement is available by clicking on the image or link below: MALVERN, Pa., May 02, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial...
May 01, 2023 08:46 ET | Source: Neuronetics

Neuronetics Announces Lisa Metzner-Rosas as SVP, Chief Marketing Officer

MALVERN, Pa., May 01, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...